COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 14:39, il y a 3 mois 21 jours Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.50% interest in Dowlais Group plc's 1p ordinary securities, with recent purchases at 0.83 GBP per unit Securities Vanguard Group Stock Purchases Interest Disclosure Dowlais Group
BRÈVE publiée le 27/10/2025 à 14:39, il y a 3 mois 21 jours The Vanguard Group Discloses Stake in Avadel Pharmaceuticals Form 8.3 Vanguard Group Stake Disclosure Irish Takeover Rules Avadel Pharmaceuticals
BRÈVE publiée le 27/10/2025 à 14:39, il y a 3 mois 21 jours Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Groupe Vanguard Formulaire 8.3 Divulgation Des Enjeux Règles Irlandaises En Matière De Rachat Avadel Pharmaceuticals
COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 14:38, il y a 3 mois 21 jours Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.48% stake in American Axle & Manufacturing Holdings, Inc. as of 24 October 2025 Vanguard Group Ownership Disclosure Stake Disclosure Financial Holding American Axle
COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 14:36, il y a 3 mois 21 jours Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.59% stake in Qualcomm Incorporated as of 24 October 2025. Also making disclosures related to Alphawave IP Group plc Vanguard Group Stake Disclosure Investments Qualcomm Alphawave IP
COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 14:35, il y a 3 mois 21 jours Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc., discloses a 1.81% ownership in Alphawave IP Group plc through Form 8.3 filing. Also making disclosures related to Qualcomm Incorporated Form 8.3 Disclosure Vanguard Group Qualcomm Alphawave IP Group Plc
COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 14:34, il y a 3 mois 21 jours Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% interest in Avadel Pharmaceuticals plc with 5,524,858 ordinary shares. Disclosure made on 24 October 2025 Irish Takeover Panel Vanguard Group Shareholding Interest Disclosure Avadel Pharmaceuticals
BRÈVE publiée le 24/10/2025 à 16:00, il y a 3 mois 24 jours The Vanguard Group Discloses Position in NCC Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group NCC Group
BRÈVE publiée le 24/10/2025 à 16:00, il y a 3 mois 24 jours Le groupe Vanguard divulgue sa position dans NCC Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Valeurs Mobilières Groupe NCC
BRÈVE publiée le 24/10/2025 à 15:58, il y a 3 mois 24 jours The Vanguard Group Discloses Stake in Mural Oncology Ordinary Shares The Vanguard Group Stake Disclosure Mural Oncology Takeover Rules
Publié le 17/02/2026 à 18:46, il y a 5 heures 51 minutes Covivio Hotels annual results for 2025: A solid growth trajectory
Publié le 17/02/2026 à 18:46, il y a 5 heures 51 minutes Covivio Hotels - Résultats annuels 2025 : Une trajectoire de croissance solide
Publié le 16/02/2026 à 17:45, il y a 1 jour 6 heures Cegedim : Déclaration d'actions et de droits de vote au 31 janvier 2026
Publié le 17/02/2026 à 23:00, il y a 1 heure 37 minutes Green Bridge Metals Advances Plans for H2 2026 Phase 1 Drill Program for Serpentine, Adjacent to NewRange's NorthMet and SunriseProjects, Minnesota, USA
Publié le 17/02/2026 à 22:30, il y a 2 heures 7 minutes Matador Technologies Announces Grant of Stock Options
Publié le 17/02/2026 à 22:25, il y a 2 heures 12 minutes CORRECTION FROM SOURCE: IBC Advanced Alloys Announces Execution of Definitive Funding Agreement with The Lind Partners for an Initial Funding of US$1,250,000
Publié le 17/02/2026 à 22:25, il y a 2 heures 12 minutes Zentek Provides Strategic and Regulatory Update
Publié le 17/02/2026 à 23:49, il y a 47 minutes EQS-Adhoc: Dexus Finance Pty Limited: On-market securities buyback
Publié le 17/02/2026 à 23:33, il y a 1 heure 4 minutes EQS-Adhoc: Dexus Finance Pty Limited: HY26 Results release
Publié le 17/02/2026 à 22:15, il y a 2 heures 22 minutes Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed
Publié le 17/02/2026 à 22:05, il y a 2 heures 32 minutes Immunic Announces Closing of Oversubscribed Private Placement Financing
Publié le 17/02/2026 à 19:26, il y a 5 heures 11 minutes Fuller, Smith & Turner PLC: Transaction in own shares
